Nordisk Pharma Holding ApS

CVR 42848840 · Private limited company (ApS) · Active · Medium risk

Nordisk Pharma Holding ApS is a Private limited company (ApS), founded on , based in Vallensbæk. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 340k and a net result of DKK 0. CEO: Sanad Emad Hussein Al Bidany.

Bankruptcy risk for Nordisk Pharma Holding ApS

1.6%
probability of bankruptcy within 12 months
Medium risk

1.1 × the average (1.41%) · higher risk than 79% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Return on assets0%–5% · bankruptcy rate 5.8%0.66×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42848840
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
Stenkløvervænget 21
2625 Vallensbæk
Municipality
Vallensbæk
Industry
Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 340k
Auditor
ReviTotalStatsautoriseret Revisionsfirma
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityNo
Equity ratio86.4%
Current ratio100%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 0DKK 0
Net profitDKK 0DKK 0
EquityDKK 340kDKK 340k
Total assetsDKK 393kDKK 340k
Short-term debtDKK 53k–
Tax owedDKK 53k–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · ReviTotalStatsautoriseret Revisionsfirma.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025161
1 Jan 2024 – 31 Dec 2024173
1 Jan 2023 – 31 Dec 2023161
17 Nov 2021 – 31 Dec 2022165

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOSanad Emad Hussein Al BidanyCurrent
Owner (50%)Sayed Edris SadatCurrent
Owner (50%)Sanad Emad Hussein Al BidanyCurrent
FounderSayed Edris SadatCurrent
FounderSanad Emad Hussein Al BidanyCurrent

The CEOs' other companies

Sanad Emad Hussein Al Bidany – 2 other companies

Address history (0 moves)

Stenkløvervænget 21, 2625 Vallensbæk

Other companies at the same address

Similar companies in Vallensbæk

Questions and answers about Nordisk Pharma Holding ApS

Has Nordisk Pharma Holding ApS gone bankrupt?

No, Nordisk Pharma Holding ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Nordisk Pharma Holding ApS?

Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.

Who is the CEO of Nordisk Pharma Holding ApS?

Sanad Emad Hussein Al Bidany is the CEO of Nordisk Pharma Holding ApS.

Who is the auditor of Nordisk Pharma Holding ApS?

Nordisk Pharma Holding ApS most recently used ReviTotalStatsautoriseret Revisionsfirma.

When was Nordisk Pharma Holding ApS founded?

Nordisk Pharma Holding ApS was founded on 17 November 2021.

What is the equity of Nordisk Pharma Holding ApS?

Equity was DKK 340k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.